110 related articles for article (PubMed ID: 17407708)
21. [Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B].
Yoo BC; Kim HJ; Do JH; Park SM
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):381-8. PubMed ID: 12506242
[TBL] [Abstract][Full Text] [Related]
22. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
23. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
Truong BX; Seo Y; Kato M; Hamano K; Ninomiya T; Katayama M; Kato H; Yano Y; Hayashi Y; Kasuga M
Int J Mol Med; 2005 Aug; 16(2):279-84. PubMed ID: 16012762
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
[TBL] [Abstract][Full Text] [Related]
26. A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.
Tsukada H; Ochi H; Maekawa T; Abe H; Fujimoto Y; Tsuge M; Takahashi H; Kumada H; Kamatani N; Nakamura Y; Chayama K
Gastroenterology; 2009 May; 136(5):1796-805.e6. PubMed ID: 19208361
[TBL] [Abstract][Full Text] [Related]
27. The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population.
Cao B; Liu X; Hou F; Li W; Han Z; Zhang Q; Dai Y; Xu C; Qi H
Liver Int; 2009 Oct; 29(9):1383-8. PubMed ID: 19744071
[TBL] [Abstract][Full Text] [Related]
28. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
29. [Association between single nucleotide polymorphisms in -88 and -123 loci of MxA gene promoter region and HCV susceptibility and IFN-α efficacy].
Hu CH; Chen J; Yang R; Li NN; Yang B; Ma D; Liang XC; Wang Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1307-10. PubMed ID: 23232524
[TBL] [Abstract][Full Text] [Related]
30. Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.
Shaker OG; Abdel-Rahim MT; Bayoumi ST
Cell Biochem Biophys; 2015 Mar; 71(2):617-25. PubMed ID: 25239021
[TBL] [Abstract][Full Text] [Related]
31. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon.
Hijikata M; Ohta Y; Mishiro S
Intervirology; 2000; 43(2):124-7. PubMed ID: 10971132
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.
Knapp S; Yee LJ; Frodsham AJ; Hennig BJ; Hellier S; Zhang L; Wright M; Chiaramonte M; Graves M; Thomas HC; Hill AV; Thursz MR
Genes Immun; 2003 Sep; 4(6):411-9. PubMed ID: 12944978
[TBL] [Abstract][Full Text] [Related]
33. Differential transcriptional expresión of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment.
Fernández-Arcás N; Blanco A; Gaitán MJ; Nyqvist M; Alonso A; Reyes-Engel A
Pharmacogenetics; 2004 Mar; 14(3):189-93. PubMed ID: 15167707
[TBL] [Abstract][Full Text] [Related]
34. [Predictors and scoring system for sustained complete response to conventional interferon-alpha therapy on chronic hepatitis B].
Hong MZ; Fang KN; Mao QG; Huang WQ; Xia T; Song MN; Zhang RM; Pan JS
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):738-42. PubMed ID: 22409844
[TBL] [Abstract][Full Text] [Related]
35. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection.
MacQuillan GC; de Boer WB; Platten MA; McCaul KA; Reed WD; Jeffrey GP; Allan JE
J Med Virol; 2002 Oct; 68(2):197-205. PubMed ID: 12210408
[TBL] [Abstract][Full Text] [Related]
36. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy.
Antonelli G; Simeoni E; Turriziani O; Tesoro R; Redaelli A; Roffi L; Antonelli L; Pistello M; Dianzani F
J Interferon Cytokine Res; 1999 Mar; 19(3):243-51. PubMed ID: 10213463
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the Relation Between SNP in MxA Gene and the Responsiveness of Egyptian HCV Genotype 4 Patients to Pegylated Interferon and Ribavirin Treatment.
Hassany M; Gamal A; Zaki N; Eysa B
Gastroenterology Res; 2017 Apr; 10(2):100-105. PubMed ID: 28496530
[TBL] [Abstract][Full Text] [Related]
38. MxA and PKR expression in chronic hepatitis C.
Giannelli G; Guadagnino G; Dentico P; Antonelli G; Antonaci S
J Interferon Cytokine Res; 2004 Nov; 24(11):659-63. PubMed ID: 15684819
[TBL] [Abstract][Full Text] [Related]
39. Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus.
Xiao C; Qin B; Chen L; Liu H; Zhu Y; Lu X
J Viral Hepat; 2012 Feb; 19(2):e1-10. PubMed ID: 22239505
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.
Hamdi N; El-Akel W; El-Serafy M; Esmat G; Sarrazin C; Abdelaziz AI
Intervirology; 2012; 55(3):210-8. PubMed ID: 21597279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
